Cargando…

Plasma DNA Integrity as a Prognostic Biomarker for Colorectal Cancer Chemotherapy

OBJECTIVES: To verify whether the concentrations and integrity index of circulating cell-free DNA (cfDNA) in serum may be clinically useful for the progression monitoring of colorectal cancer (CRC) patients. METHODS: Serum samples were collected from 76 primary CRC patients who underwent surgery, in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Feng, Ma, Jing, Ru, Dongdong, Wu, Ningning, Zhang, Yunhua, Li, Huiyuan, Liu, Xiaoli, Li, Jianfeng, Zhang, Huiling, Xu, Yue, Zhao, Jiangman, Tang, Hui, Wang, Yusheng, Fu, Weihua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8175143/ https://www.ncbi.nlm.nih.gov/pubmed/34135960 http://dx.doi.org/10.1155/2021/5569783

Ejemplares similares

Plasma Mesothelin as a Novel Diagnostic and Prognostic Biomarker in Colorectal Cancer
por: Li, Shuwei, et al.
Publicado: (2017)

NPM1A in Plasma is a Potential Prognostic Biomarker in Acute Myeloid Leukemia
por: Sun, Chengming, et al.
Publicado: (2018)

Plasma cell-free DNA integrity: a potential biomarker to monitor the response of breast cancer to neoadjuvant chemotherapy
por: Wang, Wei, et al.
Publicado: (2019)

Prognostic and predictive significance of circulating biomarkers in patients with advanced upper gastrointestinal cancer undergoing systemic chemotherapy
por: Li, Ningning, et al.
Publicado: (2023)

SELE gene as a characteristic prognostic biomarker of colorectal cancer
por: Li, Na, et al.
Publicado: (2021)

Excision Repair Cross-complementation Group 1 is a Prognostic Biomarker in Patients with Colorectal Cancer Receiving Chemotherapy
por: Li, Mu-Xing, et al.
Publicado: (2016)

Immunohistochemistry‐Based Consensus Molecular Subtypes as a Prognostic and Predictive Biomarker for Adjuvant Chemotherapy in Patients with Stage II Colorectal Cancer
por: Li, Yaqi, et al.
Publicado: (2020)

Inflammatory genes are novel prognostic biomarkers for colorectal cancer
por: Jiang, Hao, et al.
Publicado: (2018)

Cell-free circulating tumor RNAs in plasma as the potential prognostic biomarkers in colorectal cancer
por: Jin, Nana, et al.
Publicado: (2023)

THBS2 is a Potential Prognostic Biomarker in Colorectal Cancer
por: Wang, Xue, et al.
Publicado: (2016)

Integrative Gene Expression Profiling Analysis to Investigate Potential Prognostic Biomarkers for Colorectal Cancer
por: Liu, Xinkui, et al.
Publicado: (2020)

Serum exosomal miR-122 as a potential diagnostic and prognostic biomarker of colorectal cancer with liver metastasis
por: Sun, Li, et al.
Publicado: (2020)

CHSY3 can be a Poor Prognostic Biomarker and Mediates Immune Evasion in Stomach Adenocarcinoma
por: Li, Xinwei, et al.
Publicado: (2022)

Identification of NEO1 as a prognostic biomarker and its effects on the progression of colorectal cancer
por: Zhang, Meng, et al.
Publicado: (2020)

Prognostic value of circulating plasma cells in patients with multiple myeloma: A meta-analysis
por: Li, Jia, et al.
Publicado: (2017)

YAP Levels Combined with Plasma CEA Levels Are Prognostic Biomarkers for Early-Clinical-Stage Patients of Colorectal Cancer
por: Xu, Zihui, et al.
Publicado: (2019)

Partner of Sld five 3: a potential prognostic biomarker for colorectal cancer
por: Sun, Xiaoli, et al.
Publicado: (2014)

Significance of plasma MACC1 levels on the prognostic stratification in patients with colorectal cancer
por: Lin, Aifen, et al.
Publicado: (2018)

Prognostic value of blood-based fibrosis biomarkers in patients with metastatic colorectal cancer receiving chemotherapy and bevacizumab
por: Nissen, Neel I., et al.
Publicado: (2021)

Integrated Analysis Identifies DPP7 as a Prognostic Biomarker in Colorectal Cancer
por: Zhang, Wei, et al.
Publicado: (2023)

Clinical efficacy of chemotherapy in colorectal cancer patients over 80 years old
por: Zhang, Dongdong, et al.
Publicado: (2022)

Prognostic Value of Colorectal Cancer Biomarkers
por: Bianchi, Paolo, et al.
Publicado: (2011)

Plasma and tumor levels of Linc-pint are diagnostic and prognostic biomarkers for pancreatic cancer
por: Li, Le, et al.
Publicado: (2016)

Transcobalamin I: a novel prognostic biomarker of neoadjuvant chemotherapy in locally advanced hypopharyngeal squamous cell cancers
por: Wang, Ying, et al.
Publicado: (2018)

Pseudogenes and the associated ceRNA network as potential prognostic biomarkers for colorectal cancer
por: Li, Zhuoqi, et al.
Publicado: (2022)

Integrated Multidimensional Analysis Is Required for Accurate Prognostic Biomarkers in Colorectal Cancer
por: Mariani, Marisa, et al.
Publicado: (2014)

The prognostic factors and multiple biomarkers in young patients with colorectal cancer
por: Wang, Mo-Jin, et al.
Publicado: (2015)

Identification of ZNF26 as a Prognostic Biomarker in Colorectal Cancer by an Integrated Bioinformatic Analysis
por: Liu, Jiaxin, et al.
Publicado: (2021)

KRAS and BRAF Mutations as Prognostic and Predictive Biomarkers for Standard Chemotherapy Response in Metastatic Colorectal Cancer: A Single Institutional Study
por: Garcia-Carbonero, Nuria, et al.
Publicado: (2020)

CILP2: A prognostic biomarker associated with immune infiltration in colorectal cancer
por: Wang, Xueli, et al.
Publicado: (2023)

Plasma miRNAs as Diagnostic and Prognostic Biomarkers for Ovarian Cancer
por: Zheng, Hong, et al.
Publicado: (2013)

MTUS1 is a promising diagnostic and prognostic biomarker for colorectal cancer
por: Cheng, Lin-Yao, et al.
Publicado: (2022)

Growth differentiation factor 15 is a promising diagnostic and prognostic biomarker in colorectal cancer
por: Li, Chen, et al.
Publicado: (2016)

The effectiveness of plasma miR-33a-5p as a predictive biomarker for the efficacy of colorectal cancer chemotherapy
por: Sasaki, Megumi, et al.
Publicado: (2021)

Detection of ctDNA in the plasma of patients with papillary thyroid carcinoma
por: Li, Huiqiang, et al.
Publicado: (2019)

DHX37 Is a Promising Prognostic Biomarker and a Therapeutic Target for Immunotherapy and Chemotherapy in HCC
por: Liu, Nanbin, et al.
Publicado: (2023)

Identification of novel protein biomarkers and drug targets for colorectal cancer by integrating human plasma proteome with genome
por: Sun, Jing, et al.
Publicado: (2023)

Pretreatment plasma fibrinogen level as a prognostic biomarker for patients with lung cancer
por: Zhang, Yi, et al.
Publicado: (2020)

GJA1 is a Prognostic Biomarker and Correlated with Immune Infiltrates in Colorectal Cancer
por: Hu, Wenjun, et al.
Publicado: (2020)

The prognostic role of fasting plasma glucose levels on survival in advanced colorectal cancer patients with type II diabetes mellitus: a retrospective cohort study
por: Meng, Qianhao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_j4ck8b1ghvum61voi5cpdek1ie